(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

TERAPIA DE COMBINAÇÃO QUE COMPREENDE COMPOSTOS DA FÓRMULA (I) E AGONISTAS DE RECEPTOR DE GLP-1

Em ExigênciaInvention PatentPCT · EP2020060283

Application data

Number

112021020234

Type

Invention Patent

Filing

04/09/2020

Publication

12/07/2021

PCT

EP2020060283

Progress at the INPI

Technical opinion to answer
  1. Filing04/09/20
  2. Publication12/07/21
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 12/10/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

GENFIT

FR

See this company's full portfolio

Inventors

E. D. (pessoa física)

FR

R. W. (pessoa física)

FR

V. L. (pessoa física)

FR

Technical data

Priority claims

EP

19305468.1 · 04/10/2019

Abstract

TERAPIA DE COMBINAÇÃO QUE COMPREENDE COMPOSTOS DA FÓRMULA (I) E AGONISTAS DE RECEPTOR DE GLP-1. A presente invenção se refere a uma terapia de combinação que compreende um agonista de PPAR e um agonista de receptor de GLP-1.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Parecer de pré-exame

#6.23

12/10/2024

RPI 2814

Notificação de entrada na fase nacional - PCT

#1.3

12/07/2021

RPI 2657

Alteração de dados cadastrais

#1.1

10/19/2021

RPI 2650

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.